Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Articles published by Business Wire

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

ASCO 2026: Bayer Shares New Findings for NUBEQA® (darolutamide) Regarding Cognitive Decline in Men with Advanced Prostate Cancer Compared to Enzalutamide in Phase II ARACOG Head-to-Head Trial

Today 17:24 EDT

From Bayer

Via Business Wire

Salubris Biotherapeutics Announces Updated Phase 1/2 Data for JK06, a 5T4-Targeted Antibody Drug Conjugate, at the 2026 American Society of Clinical Oncology Annual Meeting

Today 14:30 EDT

From Salubris Biotherapeutics, Inc.

Via Business Wire

BW LPG Enters Into Agreement for Eight 90’cbm Panamax Newbuildings with Hyundai Heavy Industries

Today 12:03 EDT

From BW LPG Limited

Via Business Wire

Mirum Pharmaceuticals Announces New Data from Rare Liver Disease Programs Presented at the EASL International Liver Congress 2026

Today 12:00 EDT

From Mirum Pharmaceuticals, Inc.

Via Business Wire

INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Sportradar Group AG (SRAD) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Today 11:00 EDT

From Robbins Geller Rudman & Dowd LLP

Via Business Wire

CVLT INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Commvault Systems, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Today 11:00 EDT

From Robbins Geller Rudman & Dowd LLP

Via Business Wire

Exelixis Announces Results from Subgroup Analysis of Phase 3 CABINET Pivotal Trial Evaluating CABOMETYX® (cabozantinib) in Non-Functional and Functional Neuroendocrine Tumors at ASCO 2026

Today 10:00 EDT

From Exelixis, Inc.

Via Business Wire

Massive Bio Announces Next-Generation Reticulum Nexus™ Product Suite at ASCO 2026

Today 10:00 EDT

From Massive Bio

Via Business Wire

Tempus Launches the PRECISION Challenge, a National Program Opening Its Foundation Model Work to the Broader Research Community

Today 8:30 EDT

From Tempus AI, Inc.

Via Business Wire

Encouraging Global Phase II Ivonescimab Data in First-Line Metastatic Colorectal Cancer Presented at ASCO 2026

Today 8:00 EDT

From Summit Therapeutics

Via Business Wire

ENZAMET Trial Shows Veracyte's Decipher Prostate Test Identifies Which Patients Benefit from Adding Chemotherapy in Metastatic Prostate Cancer

Today 8:00 EDT

From Veracyte, Inc.

Via Business Wire

Incyte’s Pivotal frontMIND Trial Showed Tafasitamab (Monjuvi®/Minjuvi®) Combination Significantly Prolonged Progression-free Survival, Reducing the Risk of Disease Progression or Death by 25% in Patients with Previously Untreated, High-risk DLBCL

Today 8:00 EDT

From Incyte

Via Business Wire

Tempus Introduces ‘Preview’: Bridging the Critical Time Gap Between Diagnostic Order and Definitive Results

Today 8:00 EDT

From Tempus AI, Inc.

Via Business Wire

Immunome Announces Detailed Phase 3 RINGSIDE Data for Varegacestat in Adults with Progressing Desmoid Tumors at the 2026 ASCO Annual Meeting

Today 8:00 EDT

From Immunome, Inc.

Via Business Wire

TALZENNA Plus XTANDI Improves Radiographic Progression-Free Survival by More Than 50% in Metastatic Prostate Cancer

Today 8:00 EDT

From Pfizer Inc.

Via Business Wire

Tune Therapeutics Presents Positive Phase 1b/2a Proof of Concept Data on TUNE-401: a First-in-Class Epigenetic Silencer for Patients with Hepatitis B at EASL 2026

Today 8:00 EDT

From Tune Therapeutics

Via Business Wire

FCPT Announces Agreement to Acquire up to 102 Mission Pet Health Veterinary Properties for $268 Million

May 29, 2026

From Four Corners Property Trust

Via Business Wire

AVAV INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that AeroVironment, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

May 29, 2026

From Robbins Geller Rudman & Dowd LLP

Via Business Wire

Shareholder Notice: Robbins LLP Informs Investors of the Lucid Group, Inc. Class Action

May 29, 2026

From Robbins LLP

Via Business Wire

Ferrari Films Issues Formal Rebuttal to Forbes Article Mischaracterizing Section 168(k) as "Worthless" for Film Investors

May 29, 2026

From Ferrari Films

Via Business Wire

YSS INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving York Space Systems Inc.

May 29, 2026

From Kirby McInerney LLP

Via Business Wire

Tanner Introduces New AI Voice Chat Assistant to Reduce Call Center Hold Times

May 29, 2026

From Tanner Health

Via Business Wire

KBRA Assigns AA+ Rating to State of Illinois, Build Illinois Bonds (Sales Tax Revenue), Junior Obligation Series A and B of June 2026; Affirms Parity Debt; Stable Outlook

May 29, 2026

From Kroll Bond Rating Agency, LLC

Via Business Wire

Syncora Guarantee Inc. Announces the Availability of Certain Financial Information

May 29, 2026

From Syncora Guarantee Inc.

Via Business Wire

$910 Million Student Housing Portfolio Sale Facilitated by Institutional Property Advisors

May 29, 2026

From Marcus & Millichap, Inc.

Via Business Wire

Sable Offshore Corp. to Host Conference Call on June 1, 2026

May 29, 2026

From Sable Offshore Corp.

Via Business Wire

SABA Announces Notification of Sources of Distributions

May 29, 2026

From Saba Capital Income & Opportunities Fund II

Via Business Wire

BRW Announces Notification of Sources of Distributions

May 29, 2026

From Saba Capital Income & Opportunities Fund

Via Business Wire

Kraken Set to Launch First CFTC-Regulated Perpetual Futures for US Traders

May 29, 2026

From Kraken

Via Business Wire

Corcept Presents New Data at ASCO 2026: Lifyorli™ Overall Survival Across All Subgroups of Patients with Platinum-Resistant Ovarian Cancer, Including Those with Recent Taxane Exposure

May 29, 2026

From Corcept Therapeutics Incorporated

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.